Pilot Study to Study the Time Between Pleuropulmonary Ultrasound and Antibiotic Therapy Prescription in Patients Admitted to the Emergency Department for Suspected Pneumonia

N/ANot Yet RecruitingNCT07703852

University Hospital, Grenoble15 enrolled

Overview

Pneumonia is a common pathology with significant morbidity and mortality. It is recommended in his diagnostic approach to perform either a chest X-ray or a pleuropulmonary ultrasound. Previous studies have shown the advantages of ultrasound in terms of diagnostic performance cost and patient irradiation. However, it remains little used in clinical practice.

The study will be conducted in the Emergency Department of grenoble University Hospital. Patient admitted to the emergency department for respiratory symptoms (cough, fever, and/or dyspnea) will be enrolled in the study according to the inclusion and non-inclusion criteria and after obtaining his consent. The investigator will perform the pleuropulmonary ultrasound following the clinical examination carried out by the physician in charge of the patient. The patient's care is unaffected by the pleuropulmonary ultrasound's outcome, which is unknown to the physician in charge of the patient. Data collection after the patient's discharge from the emergency department.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Pneumonia

Interventions

Pleuropulmonary ultrasound performed by the investigator for patient with suspicion od PneumoniaPROCEDURE

In addition to the traditional management done by the physician at the patient's expense (such as clinical examination and paraclinical examinations like biology, chest X-ray, etc.), the investigator will perform pleuropulmonary ultrasound.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient over 18 years admitted the the emergency department of Grenoble Alpes University Hospital with respiratory symptoms (cough and/or dyspnea, fever). * No objection by the subject to the study * Affiliated to the french social security system (or equivalent) Exclusion Criteria: * Patient admitted to a life-threatening emergency * Patient already on antibiotic therapy on admission * Patient excluded from another study * Patient with respiratory signs following chest trauma * Unable to communicate or non-french speaking patients or those with impaired comprehension or consciousness * Protected persons referred to in articles L1121-6 and L1121-8 of French public health code (deprived of liberty, tutorship or curatorship) * The patient already enrolled in the study

Outcomes

Primary Outcomes

Time between the antibiotic prescription and the pleuropulmonary ultrasonography used to detect pneumonia

Time frame: 1 hour

Secondary Outcomes

Calculation of the predictive values of the pleuropulmonary ultrasound for pneumonia diagnosis

Calculation of the predictive values of the pleuropulmonary ultrasound for pneumonia diagnosis: area under the curve, sensitivity, specificity, positive predictive value, negative predictive value.

Time frame: 1 day

duration of performing the pleuropulmonary ultrasound

Time frame: 5 minutes

Time between the patient's admission to the emergency department and the completion of the pleuropulmonary ultrasound

Time frame: 1 hour

4. Time between the performance of the pleuropulmonary ultrasound and the performance of the chest X-ray

4\. Time between the performance of the pleuropulmonary ultrasound and the performance of the chest X-ray

Time frame: 2 hours

Central Contacts

Alice GREMBER, MD

CONTACT

0033476766784 AGrember@chu-grenoble.fr

Marcelline BUFFIN

CONTACT

0033476766784 Mbuffin@chu-grenoble.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.